Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Ultragenyx Pharmaceutical Inc. | Officer | Common Stock | 115K | $4.92M | $42.92 | Mar 3, 2025 | Direct |
Ultragenyx Pharmaceutical Inc. | Officer | Stock Option (Right to Buy) | 26.1K | Mar 1, 2025 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
RARE | Ultragenyx Pharmaceutical Inc. | Mar 1, 2025 | 4 | -$57.9K | 4 | Mar 4, 2025 | Officer |
RARE | Ultragenyx Pharmaceutical Inc. | Mar 1, 2024 | 4 | -$25.2K | 4 | Mar 5, 2024 | EVP, Chief Technical Operations Officer |
RARE | Ultragenyx Pharmaceutical Inc. | Mar 1, 2023 | 5 | -$502K | 4 | Mar 3, 2023 | EVP, Chief Technical Operations Officer |
RARE | Ultragenyx Pharmaceutical Inc. | Mar 1, 2022 | 3 | -$215K | 4 | Mar 3, 2022 | EVP, Chief Technical Operations Officer and Gene Therapy Operations |
RARE | Ultragenyx Pharmaceutical Inc. | Oct 14, 2021 | 1 | -$29K | 4 | Oct 18, 2021 | EVP & Chief Tech Ops Officer |
RARE | Ultragenyx Pharmaceutical Inc. | May 6, 2021 | 1 | -$41.3K | 4 | May 10, 2021 | EVP & Chief Tech Ops Officer |